Skip to main content
SpringerLink
Log in

Inotropic Agents: An Overview

  • Chapter
Clinical Pharmacology & Therapeutics

  • 387 Accesses

Abstract

Improvement in myocardial contractility by inotropic agents is a critical component in the management of heart failure. Unfortunately although many drugs have been shown to have positive inotropic effects on the heart, few of these agents have been found to be useful in the treatment of heart failure in man (Farah & Alousi, 1978). This review will concentrate on drugs which appear to have the greatest potential for clinical use.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Akera, T. & Brody, T. M. (1977). The role of Na+, K+-ATPase in the inotropic action of digitalis. Pharmac. Rev., 29, 187–220.

    CAS  Google Scholar 

  • Alexander, C. S., Sako, Y. & Mikulic, E. (1975). Pedal gangrene associated with the use of dopamine. New Eng. J. Med., 293, 591.

    Article  CAS  PubMed  Google Scholar 

  • Allen, D. G & Blinks, J. R.(1978). Calcium transients in aegnoun-injected frog cardiac muscle. Nature, 273, 509–513.

    Article  CAS  PubMed  Google Scholar 

  • Alousi, A. A., Farah, A. E., Lesher, G. Y. & Opalka, C. J., Jr. (1979). Cardiotonic activity of amrinone-WIN 40680 (5-amino-3,4’-bipyridin-6(1H)-one). Circulation Res., 45, 666–677.

    Article  CAS  PubMed  Google Scholar 

  • Beller, G. A., Smith, T. W., Abelmann, W. H., Haber, E. & Hood, W. B., Jr. (1971). Digitalis intoxication. New Eng. J. Med., 284, 989–997.

    Article  CAS  PubMed  Google Scholar 

  • Benotti, J. R., Grossman, W., Braunwald, E., Davolds, D. D. & Alousi, A. A. (1978). Hemodynamic assessment of amrinone. New Eng. J. Med., 299, 1373–1377.

    Article  CAS  PubMed  Google Scholar 

  • Beregovich, J., Bianchi, C., Rubier, S., Lomnitz, E., Cagin, N. & Levitt, B. (1974). Dose-related hemodynamic and renal effects of dopamine in congestive heart failure. Am. Heart J., 87, 550–557.

    Article  CAS  PubMed  Google Scholar 

  • Braunwald, E. (1971). Control of myocardial oxygen consumption. Am. J. Cardiol., 27, 416–432.

    Article  CAS  PubMed  Google Scholar 

  • Carliner, N. H., Gilbert, C. A., Pruitt, A. W. & Goldberg, L. I. (1974). Effects of maintenance digoxin therapy on systolic time intervals and serum digoxin concentrations. Circulation 50,94–98.

    Article  CAS  PubMed  Google Scholar 

  • Chan, V., Tse, T. F. & Wong, V. (1978). Transfer of digoxin across the placenta and into breast milk. Brit. J. Obst. Gvnec., 85, 607–609.

    Google Scholar 

  • Covel, J. W., Braunwald, E., Ross, J., Jr., & Sonnenblick, E. H. (1966). Studies on digitalis. XVI. Effects on myocardial oxygen consumption. J. clin. Invest., 45, 1535–1542.

    Article  Google Scholar 

  • DeiCas, L., Manca, C., Vansini, G., Mansour, M., Bernardini, B. & Visioli, O. (1980). Noninvasive evaluation of left ventricular function through systolic time intervals following oral administration of SB 7505 in man. Arzneimettel Forschung. Drug Research, 30, 498–499.

    CAS  Google Scholar 

  • Doering, W. (1979). Quinidine-digoxin interaction. New Eng. J. Med., 301, 400–409.

    Article  CAS  PubMed  Google Scholar 

  • Ewy, G. A., Kapadia, G. G., Yao, L., Lullin, M. & Marcus, F. I. (1969). Digoxin metabolism in the elderly. Circulation, 39, 449–453.

    Article  CAS  PubMed  Google Scholar 

  • Farah, A. E. & Alousi, A. A. (1978). New cardiotonic agents: A search for digitalis substitute Life Sci., 22, 1139–1148.

    Article  CAS  PubMed  Google Scholar 

  • Finlay, G. D., Whitsett, T. L., Cucinell, E. A. & Goldberg, L. I. (1971). Augmentation of sodium and potassium excretion, glomerular filtration data and renal plasma flow by levodopa. New Eng. J. Med., 284, 865–870.

    Article  CAS  PubMed  Google Scholar 

  • Glick, G., Parmley, W. W., Wechsler, A. S. & Sonnenblick, E. H. (1963). Glucagon. Circulation Res., 22, 789–799.

    Article  Google Scholar 

  • Goldberg, L. I. (1972). Cardiovascular and renal actions of dopamine: Potential clinical applications. Pharmac. Rev., 24, 1–29.

    CAS  Google Scholar 

  • Goldberg, L. I. (1974). Dopamine-clinical uses of an endogenous catecholamine. New Eng. J. Med. 291, 707–710.

    Article  CAS  PubMed  Google Scholar 

  • Goldberg, L. I., Hsieh, Y. & Resnekov, L. (1977). Newer catecholamines for treatment of heart failure and shock: An update on dopamine and a first look at dobutamine. Prog. Cardiovasc. Dis., 19, 327–340.

    Article  CAS  PubMed  Google Scholar 

  • Jennings, K., Jackson, P. G., Monaghan, M. & Jewitt, D. E. (1978). Some aspects of the cardiovascular pharmacology of UK 14,275 in patients with coronary artery disease. Brit. J clin Pharmac., 5, 13–18.

    Article  CAS  Google Scholar 

  • Jewitt, D., Jennings, K. & Jackson, P. G. (1978). Efficacy of new inotropic drugs in clinical coronary heart failure. Am. J. Med., 65, 197–202.

    Article  CAS  PubMed  Google Scholar 

  • Johnsson, G., Jordö, L., Lundborg, P., Rönn, O., Welin-Fogelberg, I. & Wikstrand, J. (1978). Haemodynamic and tolerance studies in man of a new, orally active, selective β 1-adrenoreceptor agonist H 80/62. Eur J Pharmac., 13, 163–170.

    Article  CAS  Google Scholar 

  • Langer, S. Z. & Dubocovich, M. L. (1979). Physiological and pharmacological role of the regulation of noradrenaline release by presynaptic dopamine receptors in the peripheral nervous system. In Advances in Biosciences, Peripheral dopaminergic receptors. Vol. 20, ed. Imbs. J.-L. & Schwartz, J., pp. 233–248. Oxford: Pergamon Press Ltd.

    Chapter  Google Scholar 

  • Leier, C. V., Heban, P. T., Huss, P., Bush, C. A. & Lewis, R. P. (1978). Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathy heart failure. Circulation, 58, 446–475.

    Article  Google Scholar 

  • LeJemtel, T. H., Keung, E., Ribner, H. S., Davis, R., Wexler, J., Blaufox, M. D. & Sonnenblick, E. H. (1980). Sustained beneficial effects of oral amnnone on cardiac and renal function in patients with severe congestive heart failure. Am. J Cardiol., 45, 123–129.

    Article  CAS  PubMed  Google Scholar 

  • LeJemtel, T. H., Keung, E., Sonnenblick, E. H., Ribner, H. S., Matsumoto, M., Davis. R., Schwartz, W., Alousi, A. A. & Davolos, D. (1979). Amrinone: A new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation, 59, 1098–1104.

    Article  CAS  PubMed  Google Scholar 

  • McDonald, R. H., Jr., Goldberg, L. I., McNay, J. L. & Tuttle, E. P., Jr. (1964). Effect of dopamine in man: Augmentation of sodium excretion, glomerular filtration rate and renal plasma flow. J. clin. Invest., 43, 1116–1124

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mason, D. T. (1974). Digitalis pharmacology and therapeutics: Recent advances. Ann. intern. Med., 80, 520–530.

    Article  CAS  PubMed  Google Scholar 

  • Mason, D. T. & Braunwald, E. (1964). Studies on digitalis. X. Effects of ouabain on forearm vascular resistance and venous tone in normal subjects and in patients in heart failure. J. clin. Invest., 43, 532–543.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mason, D. T., Spann, J. F., Jr., & Zelis, R. (1967). New developments in the understanding of the actions of the digitalis glycosides. Prog. Cardiovasc Dis., 11, 443–478

    Article  Google Scholar 

  • Miller, R. R., Awan, N. A., Joye, J. A., Maxwell, K. S., DeMaria, A. N., Amsterdam. E. A. & Mason, D. T. (1977). Combined dopamine and nitroprusside therapy in congestive heart failure. Circulation, 55, 881–884.

    Article  CAS  PubMed  Google Scholar 

  • Robie, N. W. & Goldberg, L. I. (1975). Comparative systemic and regional hemodynamic effects of dopamine and dobutamine. Am. Heart J., 90, 340–345.

    Article  CAS  PubMed  Google Scholar 

  • Rogers, M. C., Willerson, I. T., Goldblatt, A. & Smith, T. W. (1972). Serum digoxin concentrations in the human fetus, neonate and infant. New Eng. J Med., 287, 1010–1013

    Article  CAS  PubMed  Google Scholar 

  • Schwartz, A. (1977). Symposium: Newer aspects of cardiac glycoside action. Fed Proc 36, 2207–2246.

    CAS  PubMed  Google Scholar 

  • Simanis, J. & Goldberg, L.I. (1971). The effects of glucagon on sodium, potassium and urine excretion in patients in congestive heart failure. Am. Heart J., 81, 202–219

    Article  CAS  PubMed  Google Scholar 

  • Smith, T. W. & Haber, E. (1973). Cyclic adenosine monophosphate and cardiac contractility Circulation Res., 32, 407–413.

    Article  Google Scholar 

  • Sobel, B. E. & Mayer, S. E. (1973). Cyclic adenosine monophosphate and cardiac contractility. Circulation Res., 32, 407–413.

    Article  CAS  PubMed  Google Scholar 

  • Sonnenblick, E. H., Frishman, W. H. & LeJemtel, T H. (1979). Dobutamine: A new synthetic cardioactive sympathetic amine. New Eng. J Med., 300, 17–22.

    Article  CAS  PubMed  Google Scholar 

  • Stemple, D. R., Kleiman, J. H. & Harrison. D. C. (1978). Combined nitroprusside-dopamine therapy in severe congestive heart failure. Am. J Cardiol., 42, 267–275

    Article  CAS  PubMed  Google Scholar 

  • Whitsett, T. L. & Goldberg, L. I. (1972). Effects of levodopa on systolic projection period, blood pressure, and heart rate during acute and chronic treatment of Parkinson’s disease Circulation, 45, 98–106.

    Article  Google Scholar 

  • Williams, J. F. (1969). Glucagon and the cardiovascular system. Ann. intern. Med., 71, 419–423.

    Article  PubMed  Google Scholar 

  • Wynne, J., Malacoff, R. F., Benotti, J. R., Curfman, G. D., Grossman, W. Holman, B. L. Smith, T. W. & Braunwald, E. (1980). Oral amrinone in refractory congestive heart failure Am. J Cardiol., 45, 1245–1249

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Committee on Clinical Pharmacology, Departments of Pharmacological and Physiological Sciences and Medicine, The University of Chicago, 947 East 58th Street, Chicago, IL, 60637, USA

    L. I. Goldberg & S. I. Rajfer

Authors
  1. L. I. Goldberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. I. Rajfer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

P. Turner C. Padgham A. Hedges

Copyright information

© 1980 The contributors

About this chapter

Cite this chapter

Goldberg, L.I., Rajfer, S.I. (1980). Inotropic Agents: An Overview. In: Turner, P., Padgham, C., Hedges, A. (eds) Clinical Pharmacology & Therapeutics. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-05952-2_19

Download citation

Publish with us

Policies and ethics

Search

Navigation